| $385M | ||
| $350M | ||
| $215M | ||
| $100M | ||
| $88M | ||
| $82M |
Buys | $393,486 | 2 | 13 |
Sells | $3,668,916 | 13 | 87 |
| Stewart Brady | director | 1 | $204,486 | 0 | $0 | $204,486 |
| White Albert G III | director | 1 | $189,000 | 0 | $0 | $189,000 |
| Yamagishi-Dressler Tomoko | Chief Marketing Officer | 0 | $0 | 2 | $103,097 | $-103,097 |
| Beaver Sandra | Chief Financial Officer | 0 | $0 | 2 | $184,313 | $-184,313 |
| Avelar Rui | See Remarks | 0 | $0 | 3 | $419,432 | $-419,432 |
| MOATAZEDI DAVID | See Remarks | 0 | $0 | 6 | $2.96M | $-2.96M |
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Over the last 12 months, insiders at Evolus, Inc. have bought $393,486 and sold $3.67M worth of Evolus, Inc. stock.
On average, over the past 5 years, insiders at Evolus, Inc. have bought $2.65M and sold $18.98M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Stewart Brady (director) — $204,486. White Albert G III (director) — $189,000.
The last purchase of 30,000 shares for transaction amount of $204,486 was made by Stewart Brady (director) on 2025‑08‑15.
| 2025-12-22 | Sale | Avelar Rui | See Remarks | 2,261 0.0035% | $7.15 | $16,168 | -31.50% | |
| 2025-12-22 | Sale | MOATAZEDI DAVID | See Remarks | 10,539 0.0162% | $7.15 | $75,361 | -31.50% | |
| 2025-08-22 | Sale | Yamagishi-Dressler Tomoko | Chief Marketing Officer | 5,722 0.0087% | $7.51 | $42,972 | -16.28% | |
| 2025-08-15 | Stewart Brady | director | 30,000 0.047% | $6.82 | $204,486 | -3.27% | ||
| 2025-06-16 | Sale | MOATAZEDI DAVID | See Remarks | 16,582 0.0255% | $9.89 | $164,054 | -32.48% | |
| 2025-06-13 | Sale | MOATAZEDI DAVID | See Remarks | 111,323 0.1748% | $10.05 | $1.12M | -32.23% | |
| 2025-06-09 | White Albert G III | director | 20,000 0.0304% | $9.45 | $189,000 | -30.05% | ||
| 2025-05-13 | Sale | Beaver Sandra | Chief Financial Officer | 6,494 0.01% | $10.02 | $65,070 | -32.68% | |
| 2025-05-12 | Sale | MOATAZEDI DAVID | See Remarks | 15,787 0.0242% | $9.87 | $155,756 | -31.51% | |
| 2025-05-12 | Sale | Avelar Rui | See Remarks | 3,385 0.0052% | $9.87 | $33,397 | -31.51% | |
| 2025-03-27 | Sale | MOATAZEDI DAVID | See Remarks | 6,251 0.01% | $12.40 | $77,512 | -42.40% | |
| 2025-03-18 | Sale | MOATAZEDI DAVID | See Remarks | 103,376 0.1623% | $13.26 | $1.37M | -46.50% | |
| 2025-03-18 | Sale | Avelar Rui | See Remarks | 27,904 0.0438% | $13.26 | $369,868 | -46.50% | |
| 2025-03-18 | Sale | Beaver Sandra | Chief Financial Officer | 8,996 0.0141% | $13.26 | $119,243 | -46.50% | |
| 2025-03-18 | Sale | Yamagishi-Dressler Tomoko | Chief Marketing Officer | 4,536 0.0071% | $13.26 | $60,125 | -46.50% | |
| 2025-03-12 | Sale | Parschauer Karah Herdman | director | 12,888 0.0196% | $12.99 | $167,465 | -46.65% | |
| 2024-12-23 | Sale | MOATAZEDI DAVID | See Remarks | 10,502 0.0167% | $10.85 | $113,967 | -13.75% | |
| 2024-12-23 | Sale | Avelar Rui | See Remarks | 2,252 0.0036% | $10.85 | $24,438 | -13.75% | |
| 2024-12-23 | Sale | Beaver Sandra | Chief Financial Officer | 1,586 0.0025% | $10.85 | $17,211 | -13.75% | |
| 2024-09-06 | Sale | Beaver Sandra | Chief Financial Officer | 3,276 0.0053% | $14.98 | $49,074 | -21.07% |
| Avelar Rui | See Remarks | 356821 0.5484% | $1.79M | 0 | 13 | |
| MOATAZEDI DAVID | See Remarks | 354388 0.5447% | $1.78M | 0 | 26 | |
| Beaver Sandra | Chief Financial Officer | 167089 0.2568% | $837,115.89 | 0 | 9 | |
| Yamagishi-Dressler Tomoko | Chief Marketing Officer | 89949 0.1383% | $450,644.49 | 0 | 3 | |
| Stewart Brady | director | 88629 0.1362% | $444,031.29 | 1 | 0 | |
| White Albert G III | director | 50378 0.0774% | $252,393.78 | 1 | 0 | |
| Alphaeon Corp | 10 percent owner | 8662346 13.3144% | $43.4M | 0 | 6 | |
| Alphaeon 1 LLC | 10 percent owner | 4214871 6.4784% | $21.12M | 0 | 2 | |
| Medytox Inc. | 3381326 5.1972% | $16.94M | 15 | 9 | <0.0001% | |
| Malik Vikram | director | 246514 0.3789% | $1.24M | 4 | 7 | +1.4% |
| Jafar Michael M. | See Remarks | 174851 0.2688% | $876,003.51 | 1 | 1 | <0.0001% |
| SILVERNAIL LAUREN P | See Remarks | 141571 0.2176% | $709,270.71 | 0 | 5 | |
| Muilenburg Crystal | Chief Marketing Officer | 134248 0.2063% | $672,582.48 | 0 | 2 | |
| BLANK SIMONE | 54881 0.0844% | $274,953.81 | 3 | 0 | <0.0001% | |
| GILL DAVID N | director | 33964 0.0522% | $170,159.64 | 2 | 3 | +8.2% |
| Parschauer Karah Herdman | director | 32183 0.0495% | $161,236.83 | 0 | 2 | |
| FARRELL PETER C | 10000 0.0154% | $50,100.00 | 1 | 0 | <0.0001% | |
| HAYMAN ROBERT | director | 10000 0.0154% | $50,100.00 | 3 | 0 | <0.0001% |
| Hau Bosun | director | 10040 0.0154% | $50,300.40 | 2 | 0 | <0.0001% |
| Romine Kristine | director | 3450 0.0053% | $17,284.50 | 10 | 0 | <0.0001% |
$2,061,416 | 1659 | -11.38% | $45.47M | |
$218,350,131 | 64 | 16.68% | $481.97M | |
$125,860,243 | 57 | -4.48% | $35.31M | |
$129,489,279 | 57 | 26.09% | $339.61M | |
$2,767,882 | 51 | 8.70% | $36.04M | |
$30,218,950 | 47 | -3.19% | $25.12M | |
$33,884,330 | 45 | 12.58% | $376.68M | |
Evolus, Inc. (EOLS) | $97,642,477 | 41 | -10.58% | $325.95M |
$6,021,989 | 30 | -0.17% | $399.21M | |
$32,539,771 | 28 | 33.37% | $149.51M | |
$25,034,841 | 20 | 9.38% | $549.51M | |
$1,843,996 | 10 | 22.92% | $835.41M | |
$1,718,514 | 9 | 38.13% | $697.6M | |
$758,061 | 9 | 60.03% | $166.42M | |
$8,190,853 | 8 | -3.69% | $20.57M | |
$208,823 | 7 | -1.10% | $74.05M | |
$179,515 | 7 | 1.51% | $423.84M | |
$543,932 | 6 | -22.06% | $520.54M | |
$12,300,713 | 4 | 24.14% | $245.03M |
| Increased Positions | 93 | +49.47% | 11M | +19.97% |
| Decreased Positions | 80 | -42.55% | 17M | -30.47% |
| New Positions | 41 | New | 7M | New |
| Sold Out Positions | 31 | Sold Out | 7M | Sold Out |
| Total Postitions | 201 | +6.91% | 49M | -10.5% |
| Nantahala Capital Management, Llc | $38,484.00 | 8.81% | 5.73M | +2M | +36.42% | 2025-09-30 |
| Tang Capital Management Llc | $36,881.00 | 8.44% | 5.49M | +490,900 | +9.82% | 2025-09-30 |
| Blackrock, Inc. | $30,083.00 | 6.89% | 4.48M | +292,635 | +6.99% | 2025-09-30 |
| Caligan Partners Lp | $27,814.00 | 6.37% | 4.14M | +796,973 | +23.85% | 2025-09-30 |
| Vanguard Group Inc | $23,042.00 | 5.28% | 3.43M | +110,693 | +3.34% | 2025-09-30 |
| Frazier Life Sciences Management, L.P. | $17,678.00 | 4.05% | 2.63M | +195,115 | +8.01% | 2025-09-30 |
| Millennium Management Llc | $12,493.00 | 2.86% | 1.86M | +375,577 | +25.32% | 2025-09-30 |
| Stonepine Capital Management, Llc | $10,325.00 | 2.36% | 1.54M | +619,891 | +67.64% | 2025-09-30 |
| State Street Corp | $10,182.00 | 2.33% | 1.52M | +108,623 | +7.72% | 2025-09-30 |
| Eversept Partners, Lp | $9,913.00 | 2.27% | 1.48M | +304,798 | +26.04% | 2025-09-30 |